Clinical trial
Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer
NCT00176735 · University of Michigan Rogel Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00176735 |
|---|---|
| Title | Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer |
| Official title | Pilot Trial of Capecitabine and Radiation Therapy With Pre and Post Combination Chemotherapy in Advanced Pancreatic Cancer |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | Capecitabine |
| Start date | Dec 1, 2001 |
| Completion | Aug 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | May 20, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: